Document is current
Any future updates will be listed below
-
Authors
Kawai, Keita
Iwamoto, Kunihiro
Miyata, Seiko
Fujishiro, Hiroshige
Ikeda, Masashi
Ozaki, Norio
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP21K07518)
Japan Society for the Promotion of Science (JP23K10934)
Aichi Health Promotion Foundation
Japan Agency for Medical Research and Development (JP24zf0127011)
- License Information
-
More Information
Article History
Received: 29 July 2025
Accepted: 6 March 2026
First Online: 28 March 2026
Declarations
:
: KI reports personal fees from DAIICHI SANKYO, Eisai, Lundbeck Japan, MSD, Otsuka, Shionogi, Sumitomo Pharma, Takeda, and Viatris, outside the submitted work.NO has received research support or speaker honoraria from, or has served as a joint researcher with, or a consultant to, Otsuka Pharmaceutical Co., Ltd., Sumitomo Pharma Co., Ltd., Viatris Inc., Eisai Co., Ltd., The KAITEKI Institute, Inc., Ricoh Co., Ltd., Mitsubishi Tanabe Pharma Co.; reports personal fees/grants from Eli Lilly, DAIICHI SANKYO, TSUMURA, Takeda, Mochida, Meiji Seika Pharma, EA Pharma, Viatris, Ricoh, Nippon Boehringer Ingelheim, Lundbeck Japan, Nihon Medi-Physics, Nippon Chemiphar, outside the submitted work. The other authors report no other conflicts of interest in this work.
